This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Apexigen Management

Management criteria checks 0/4

Apexigen's CEO is Xiaodong Yang, appointed in Jul 2022, has a tenure of 1.08 years. total yearly compensation is $1.16M, comprised of 44.5% salary and 55.5% bonuses, including company stock and options. directly owns 2.14% of the company’s shares, worth $205.22K. The average tenure of the management team and the board of directors is 1.4 years and 1.1 years respectively.

Key information

Xiaodong Yang

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage44.5%
CEO tenure1.1yrs
CEO ownership2.1%
Management average tenure1.4yrs
Board average tenure1.1yrs

Recent management updates

Recent updates

Here's Why We're Watching Apexigen's (NASDAQ:APGN) Cash Burn Situation

Aug 08
Here's Why We're Watching Apexigen's (NASDAQ:APGN) Cash Burn Situation

CEO Compensation Analysis

How has Xiaodong Yang's remuneration changed compared to Apexigen's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

-US$27m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$1mUS$517k

-US$32m

Sep 30 2022n/an/a

-US$34m

Jun 30 2022n/an/a

-US$33m

Mar 31 2022n/an/a

-US$31m

Dec 31 2021US$667kUS$419k

-US$29m

Compensation vs Market: Xiaodong's total compensation ($USD1.16M) is above average for companies of similar size in the US market ($USD738.70K).

Compensation vs Earnings: Xiaodong's compensation has increased whilst the company is unprofitable.


CEO

Xiaodong Yang (62 yo)

1.1yrs

Tenure

US$1,161,114

Compensation

Dr. Xiao-Dong Yang, MD, PhD, serves as Chief Executive Officer and Director at Apexigen, Inc. since July 2022 and served as its President since July 2022 until February 13, 2023. Dr. Yang served as Vice Pr...


Leadership Team

NamePositionTenureCompensationOwnership
Xiaodong Yang
CEO & Director1.1yrsUS$1.16m2.14%
$ 205.2k
Francis Sarena
President & COO1.6yrsUS$1.50m0.26%
$ 25.2k
Frank Hsu
Chief Medical Officer2yrsUS$1.40m0.066%
$ 6.3k
William Duke
Chief Financial Officer1.2yrsno data0.26%
$ 24.8k
Amy Wong
Senior Vice President of Finance & Operationsno dataUS$419.81k0.15%
$ 14.3k
Jason Wright
Senior Vice President of CMC1.4yrsno datano data

1.4yrs

Average Tenure

57yo

Average Age

Experienced Management: APGN's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Xiaodong Yang
CEO & Director1.1yrsUS$1.16m2.14%
$ 205.2k
Samuel Wertheimer
Independent Director1.1yrsUS$199.34k0.59%
$ 56.4k
Gordon Ringold
Independent Director3.2yrsUS$234.71k0.040%
$ 3.9k
Meenu Chhabra Karson
Independent Chairman of the Board1.2yrsUS$212.06kno data
Herbert Cross
Independent Director1.1yrsUS$236.20k0%
$ 0
Daniel Zabrowski
Independent Director1.1yrsUS$206.76kno data
Jakob Dupont
Independent Director3yrsUS$230.26k0%
$ 0
Scott Smith
Independent Director3.9yrsUS$231.96k0%
$ 0

1.1yrs

Average Tenure

61yo

Average Age

Experienced Board: APGN's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/24 11:56
End of Day Share Price 2023/08/22 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Apexigen, Inc. is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian Kemp DolliverBrookline Capital Markets
Charles ButlerD. Boral Capital LLC.
Charles ButlerRoth Capital Partners